secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2022-05-27T23:59:59+00:00
Accession:  0001178913-22-002217
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio amends ATM sales agreement with B. Riley Securities to reflect loss of foreign private issuer status
--------------------------------------------------------------------------------

- Entered into Amended and Restated At Market Issuance Sales Agreement with B. Riley Securities dated May 27, 2022.
- Amendment made to reflect that Entera Bio is no longer a foreign private issuer.
- All material terms of the original agreement remain unchanged.
- Agreement allows for at-the-market offerings of ordinary shares under a Form S-3 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/0001178913-22-002217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322002217/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-22-002217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer